Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: Scrapy Allow: / User-agent: * Disallow: /wp-admin/ Allow: |
Title | Celleron |
Description | Welcome to Celleron Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat |
Keywords | N/A |
WebSite | cellerontherapeutics.com |
Host IP | 178.79.131.222 |
Location | United Kingdom |
Site | Rank |
US$1,022,085
Last updated: 2023-05-07 22:10:32
cellerontherapeutics.com has Semrush global rank of 10,355,605. cellerontherapeutics.com has an estimated worth of US$ 1,022,085, based on its estimated Ads revenue. cellerontherapeutics.com receives approximately 117,933 unique visitors each day. Its web server is located in United Kingdom, with IP address 178.79.131.222. According to SiteAdvisor, cellerontherapeutics.com is safe to visit. |
Purchase/Sale Value | US$1,022,085 |
Daily Ads Revenue | US$944 |
Monthly Ads Revenue | US$28,304 |
Yearly Ads Revenue | US$339,647 |
Daily Unique Visitors | 7,863 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cellerontherapeutics.com. 3600 | A | cellerontherapeutics.com. 3600 | IP: 178.79.131.222 |
cellerontherapeutics.com. 3600 | NS | cellerontherapeutics.com. 3600 | NS Record: ns2.madewithjoy.org. |
cellerontherapeutics.com. 3600 | NS | cellerontherapeutics.com. 3600 | NS Record: ns1.madewithjoy.org. |
cellerontherapeutics.com. 3600 | MX | cellerontherapeutics.com. 3600 | MX Record: 0 cellerontherapeutics-com.mail.protection.outlook.com. |
cellerontherapeutics.com. 3600 | TXT | cellerontherapeutics.com. 3600 | TXT Record: v=spf1 ip4:91.238.161.177 include:spf.protection.outlook.com -all |
Menu Menu Home About Our team Strategic collaborations Pipeline Careers News Press Releases Events & Presentations Relevant Publications Contact us Welcome to Celleron Therapeutics Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat cancer. LEARN MORE Clinical products Zabinostat Zabinostat (CXD101) is a novel epigenetic regulator with immune-regulatory properties. It is an orally available small molecule with anti-tumour properties and a well-tolerated safety profile in humans. It allows tumour cells to be recognised by the immune system and has shown efficacy in colorectal cancer and lymphomas. Learn More Emactuzumab Emactuzumab (CXD301) is a humanised recombinant monoclonal antibody directed against the Colony Stimulating Factor-1 Receptor expressed on tumour-associated M2 macrophages. It effectively depletes CSF-1R positive macrophages in the tumour microenvironment. Learn More Our mission Celleron is |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Thu, 28 Oct 2021 20:38:09 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive X-UA-Compatible: IE=edge X-Redirect-By: WordPress Location: https://cellerontherapeutics.com/ Cache-Control: max-age=0 Expires: Thu, 28 Oct 2021 20:38:08 GMT Vary: Accept-Encoding HTTP/2 200 server: nginx date: Thu, 28 Oct 2021 20:38:09 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding vary: X-Forwarded-Proto,Accept-Encoding last-modified: Thu, 28 Oct 2021 19:23:13 GMT cache-control: max-age=0 expires: Thu, 28 Oct 2021 20:38:09 GMT |
Domain Name: CELLERONTHERAPEUTICS.COM Registry Domain ID: 1212775584_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.123-reg.co.uk Registrar URL: http://www.meshdigital.com Updated Date: 2020-08-15T14:20:30Z Creation Date: 2007-09-12T14:56:18Z Registry Expiry Date: 2022-09-12T14:56:18Z Registrar: 123-Reg Limited Registrar IANA ID: 1515 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.FRESHSITES.CO.UK Name Server: NS2.FRESHSITES.CO.UK DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T12:01:26Z <<< |